Gain Therapeutics, Inc. (GANX) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $18.56M | +152.9% |
| 2024 | $7.34M | -41.6% |
| 2023 | $12.58M | -33.4% |
| 2022 | $18.88M | -45.8% |
| 2021 | $34.82M | +461.4% |
| 2020 | $6.20M | +1478.7% |
| 2019 | -$449.9K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $18.56M | +152.9% |
| 2024 | $7.34M | -41.6% |
| 2023 | $12.58M | -33.4% |
| 2022 | $18.88M | -45.8% |
| 2021 | $34.82M | +461.4% |
| 2020 | $6.20M | +1478.7% |
| 2019 | -$449.9K | — |